These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24401719)

  • 21. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
    Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
    Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
    Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
    Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
    Dounousi E; Mitsis M; Naka KK; Pappas C; Lakkas L; Harisis C; Pappas K; Koutlas V; Tzalavra I; Spanos G; Michalis LK; Siamopoulos KC
    Transplant Proc; 2014 Nov; 46(9):3194-8. PubMed ID: 25420857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
    Vasilyeva MP; Rudenko TE; Kutyrina IM; Solomakhina NI
    Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular hypertrophy and LV geometry in chronic dialysis children and adolescents.
    Lumpaopong A; Tuntrakool C; Thirakhupt P; Chulamokha Y
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S202-5. PubMed ID: 16858959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H; Choi HJ; Kang HG; Ha IS; Cheong HI; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS
    Kidney Blood Press Res; 2017; 42(3):406-415. PubMed ID: 28689198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL; Ng D; Mitsnefes M; Foster BJ; Meyers K; Warady B; Furth SL
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1962-1968. PubMed ID: 27630183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
    Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
    Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.
    Kang E; Ryu H; Kim J; Lee J; Lee KB; Chae DW; Sung SA; Kim SW; Ahn C; Oh KH
    J Am Heart Assoc; 2019 Sep; 8(18):e013357. PubMed ID: 31514574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease.
    Unsal A; Kose Budak S; Koc Y; Basturk T; Sakaci T; Ahbap E; Sinangil A
    Kidney Blood Press Res; 2012; 36(1):55-64. PubMed ID: 22854270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.
    Nohara N; Io H; Matsumoto M; Furukawa M; Okumura K; Nakata J; Shimizu Y; Horikoshi S; Tomino Y
    Clin Exp Nephrol; 2016 Oct; 20(5):740-747. PubMed ID: 26707759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
    Chang JM; Chen SC; Huang JC; Su HM; Chen HC
    Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
    Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
    Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of left ventricular hypertrophy in patients with chronic kidney disease.
    Yilmaz BA; Mete T; Dincer I; Kutlay S; Sengül S; Keven K; Ertürk S
    Ren Fail; 2007; 29(3):303-7. PubMed ID: 17497444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of mitofilin in left ventricular hypertrophy in hemodialysis patients.
    Wu QS; He Q; He JQ; Chao J; Wang WY; Zhou Y; Lou JZ; Kong W; Chen JF
    Ren Fail; 2018 Nov; 40(1):252-258. PubMed ID: 29619900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.